Other
Intensive glycemic control
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(1)
Other(1)
Detailed Status
Not yet recruiting1
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
not_yet_recruiting133%
unknown133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Effects of Intensive Glycemic Control in the Postoperative Period of Neurosurgical Patients on the Incidence of Surgical Site Infection
NCT07548112
terminatednot_applicable
The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality
NCT00487162
unknownnot_applicable
The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes
NCT00850798
Clinical Trials (3)
Showing 3 of 3 trials
NCT07548112Not Applicable
Effects of Intensive Glycemic Control in the Postoperative Period of Neurosurgical Patients on the Incidence of Surgical Site Infection
NCT00487162Not Applicable
The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality
NCT00850798Not Applicable
The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3